Page last updated: 2024-10-27

gbr 12935 and Substance-Related Disorders

gbr 12935 has been researched along with Substance-Related Disorders in 2 studies

1-[2-(benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazine : An N-alkylpiperazine that consists of piperazine bearing 2-(benzhydryloxy)ethyl and 3-phenylpropyl groups at positions 1 and 4 respectively. Potent and selective inhibitor of dopamine uptake (KD = 5.5 nM in rat striatal membranes).

Substance-Related Disorders: Disorders related to substance use or abuse.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matecka, D1
Rothman, RB1
Radesca, L1
de Costa, BR1
Dersch, CM1
Partilla, JS1
Pert, A1
Glowa, JR1
Wojnicki, FH1
Rice, KC1
Hitri, A1
Casanova, MF1
Kleinman, JE1
Wyatt, RJ1

Other Studies

2 other studies available for gbr 12935 and Substance-Related Disorders

ArticleYear
Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909).
    Journal of medicinal chemistry, 1996, Nov-22, Volume: 39, Issue:24

    Topics: Animals; Carrier Proteins; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine

1996
Fewer dopamine transporter receptors in the prefrontal cortex of cocaine users.
    The American journal of psychiatry, 1994, Volume: 151, Issue:7

    Topics: Adult; Aged; Cocaine; Down-Regulation; Female; Frontal Lobe; Humans; Ligands; Male; Middle Aged; Pip

1994